Carbonic anhydrase inhibitor alleviates retinal barrier toxicity in paclitaxel-induced retinopathy and macular edema by inhibiting CAXIV. Ye YT, Niu YL, Zhou ZY, Sun Y, et al. Int Ophthalmol 2024;44:437.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ye YT, Niu YL, Zhou ZY, Sun Y, et al. Carbonic anhydrase inhibitor alleviates retinal barrier toxicity in paclitaxel-induced retinopathy and macular edema by inhibiting CAXIV. Int Ophthalmol 2024;44:437.
PMID: 39578251